Validation of Clinical and Molecular Characteristics of the Highly Favorable IMDC Risk Category in Metastatic Renal Cell Carcinoma

• By

• Martin Zarba

• Eddy Saad

• Karl Semaan

• Talal El Zarif

• Evan Ferrier

• Connor Wells

• Razane El Hajj Chehade

• Naveen S. Basappa

• Hedyeh Ebrahimi

• Mahrukh Huseni

• Romain Banchereau

• Rana R. McKay

• Lori Wood

• Benoit Beuselinck

• Cristina Suárez

• Kosuke Takemura

• Aly-Khan A. Lalani

• Haoran Li

• Lavinia Anne Spain

• Arnoud J. Templeton

• Thomas B. Powles

• Georg A. Bjarnason

• Guillermo de Velasco

• Toni K. Choueiri

• Daniel Y. C. Heng

• April 15, 2026

• Jama Network Open